Summit Therapeutics' ivonescimab poised for FDA approval, with the potential to disrupt the oncology market. Read more on ...

A Columbia University-led multicenter research effort called IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization will develop a platform and monitoring system to ...

Regulators in the U.S. and Europe recently determined that a popular group of drugs for weight loss and diabetes don't heighten the risk of suicide. New data published in the Journal of the American ...

Channel 13's Abel Garcia met with a local and a doctor to get your questions and concerns answered over new weight loss drugs LAS VEGAS (KTNV) — Chances are you or someone you know is taking one ...

The drug, nicknamed the ‘Frankenstein’ of opioids, can be up to 500 times more potent than Heroin and 50 times stronger than fentanyl. “It’s been a living hell, you lose your son,” his ...

But a new report from the Centers for Disease Control and Prevention’s National Center for Health Statistics highlights that accessing these necessary drugs isn’t always simple — about 1 in 5 older ...

Shilpa Medicare (SML) climbed 6.12% to Rs 811.25 after the company announced that it has submitted new drug application (NDA) to U.S. Food and Drug Administration (USFDA) for Oxylanthanum Carbonate.

PBRERs will be received, processed, and tracked, using a single window approach using the Drug Submission Tracking System (DSTS) through the Office of Submissions and Intellectual Property (OSIP).

has accepted its New Drug Application (NDA) for sebetralstat, a novel, investigational oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema (HAE) attacks in adult ...

KalVista Pharmaceuticals Inc. announced today that the FDA has accepted a New Drug Application (NDA) for oral plasma kallikrein inhibitor sebetralstat to treat hereditary angioedema (HAE) attacks in ...

Mobile users in Brazil are the target of a new malware campaign that delivers a new Android ... "The malicious Google Chrome extension disguises itself as a legitimate application, tricking users into ...

As a part of a new statewide drug law, House Bill 4002, the county created an optional deflection program, giving people the chance to choose treatment over jail, if they meet certain criteria.